SNAI2 cooperates with MEK1/2 and HDACs to suppress BIM- and BMF-dependent apoptosis in TERT promoter mutant cancers.
Cancers with TERT promoter mutations (TPM) display elevated RAS pathway signaling and mesenchymal traits, and associate with lower patient survival rates. We examined whether RAS pathway signaling in TPM cancers cooperates with mesenchymal features to drive resistance to apoptosis. We observed that...
Saved in:
Main Authors: | Amol Tandon, Josh Lewis Stern |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0322961 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive Computational Assessment of SNAI1 and SNAI2 in Gastric Cancer: Linking EMT, Tumor Microenvironment, and Survival Outcomes
by: Maryam Kalantari-Dehaghi, et al.
Published: (2025-06-01) -
Structural characterization of HDAC2-MTA1 complex
by: Narayan Gautam, et al.
Published: (2025-05-01) -
Exposure to tris(2,4-di-tert-butylphenyl) phosphate during adolescence induces testicular toxicity in mice: Autophagy-apoptosis interplay
by: Xiangxiang Chen, et al.
Published: (2025-09-01) -
Silibinin declines blue light-induced apoptosis and inflammation through MEK/ERK/CREB of retinal ganglion cells
by: Ying Shen, et al.
Published: (2019-12-01) -
Targeting the MEK1/2 pathway to combat Staphylococcus aureus infection and inflammation in cystic fibrosis
by: Eryn Zuiker, et al.
Published: (2025-07-01)